Marpai, Inc. (MRAI): Entry into a Material Definitive Agreement

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001844392 0001844392 2026-07-16 2026-07-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Event · Debt financing
Instrument
Debentures
Maturity
April 15, 2028
Lender
JGB Capital

Facts are quoted from the filing text and checked against it.

Original reporting
Published Jul 20, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 20, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MRAI
Bullish
medium confidence
Mentioned
$MRAI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MRAIBullishMed
01

Why it matters

Amendment No. 2 modifies the payment trigger and sets minimum annual payments for 2026-2029, aiming to reduce debt service through 2027 and improve near-term liquidity.

02

Market read

This is a creditor amendment with explicit cash-flow mechanics, which can change near-term solvency risk and financing expectations for MRAI.

03

What to watch

The amendment also restricts additional indebtedness, which could limit future financing flexibility; traders should watch for whether the company’s offering actually occurs and at what size.

Relevance 6/10Novelty 7/10Timing: Filed July 20, 2026, with same-day press release on debt restructuring and near-term liquidity.

Background

Marpai previously acquired Maestro Health, LLC via an AXA-related purchase agreement, with ongoing payments tied to net proceeds.

Company-level read

Ticker impact

$MRAIBullishMedium confidence
Context

Marpai entered Amendment No. 2 with AXA, changing debt service so payments start only after $5M in offering proceeds through Dec 31, 2026.

Expected impact

Likely supportive for the stock on liquidity relief, though magnitude may be limited by OTC liquidity and remaining leverage.

Evidence & confidence

The filing discloses concrete covenant/payment mechanics: debt service becomes contingent on $5M offering proceeds and includes specified minimal annual payments for 2026-2029, plus a restriction on new indebtedness.

Market effects

Signals that distressed or leveraged healthcare-related issuers may be able to renegotiate creditor terms to extend runway.

Limited direct regional spillover; impact is primarily issuer-specific given OTC listing.

AXA is a European insurer/creditor, but the disclosed change is company-specific rather than a broad cross-market credit event.

Counterpoint

Liquidity relief may be temporary if the company cannot generate the $5M offering proceeds needed to trigger the revised payment schedule.

Key entities

  • Marpai, Inc.

    OTC-listed issuer filing the 8-K and entering Amendment No. 2 with AXA.

  • AXA S.A.

    French société anonyme creditor/party to the amended purchase agreement.

  • Maestro Health, LLC

    Business whose membership interests were acquired under the AXA Agreement.

Related articles

$MRAIMed

Marpai Reports Second Quarter 2026 Financial Results

Marpai, Inc. (OTCQX: MRAI) reported Q2 2026 results for the three and six months ended June 30, 2026. Revenue fell to $8.6 million for six months ended June 30, 2026 from $10.1 million a year earlier. The company cited faster cost reductions improving gross margin, and amended debt maturities to 2028 and 2029. After quarter-end, it raised $12.1 million via a private placement.

$MRAIMedAI 8/10

Marpai Announces $12 Million Private Placement led by Mitchell Companies

Marpai, Inc. (OTCQX: MRAI) said it completed securities purchase agreements for a $12 million private placement of newly designated convertible preferred stock led by Mitchell Companies. The deal sold 12,100 shares at $1,000 each with a $1.00 initial conversion price. Preferred holders receive an 8% dividend in common shares and convert on a liquidity event or qualified public offering.

$MARAMed

MARA prices $185M debt offering after $1.1B Bitcoin sale

MARA priced an $185M debt offering at 8.75% interest, maturing in 2032, to finance its $1.5B acquisition of Long Ridge Energy. The deal includes a 485MW power plant and land for potential data centers. MARA recently sold $1.1B in Bitcoin to repay debt. Long Ridge generated $144M in annualized adjusted EBITDA, but interest payments may consume nearly half.

$RIOLow

Rio Tinto commits US$250m to address damage from Bougainville's Panguna mine

Rio Tinto will contribute $250m to a fund addressing environmental and human rights impacts of the Panguna mine, per an agreement with Bougainville Copper Limited, the Autonomous Bougainville Government, and community leaders. The fund aims to support practical responses to identified impacts and social projects. Details will be developed in consultation with communities.

$PLCEMed

The Children’s Place begins nationwide closing sales as the future of hundreds of stores remains uncertain

The Children's Place has begun nationwide closing sales across its 500 stores in the U.S. and Canada, following a Chapter 11 bankruptcy filing. The retailer is seeking a buyer to potentially preserve operations. Gymboree, also owned by the company, is included in the liquidation. Sales are ongoing in stores and online, with gift cards and rewards valid until Dec. 12, 2026. The company aims to complete the sale process by the end of December, but the future of stores and brands remains uncertain.